Strata Critical Medical, Inc. Class A Common Stock SRTA
$5.26
+0.77%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-11-03 | View → |
| 8-K | 8-K | 2026-11-03 | View → |
| 4 | FORM 4 | 2026-10-30 | View → |
| 4 | FORM 4 | 2026-09-25 | View → |
| 4 | FORM 4 | 2026-09-25 | View → |
| 4 | FORM 4 | 2026-09-10 | View → |
| 4 | FORM 4 | 2026-09-10 | View → |
| 4 | FORM 4 | 2026-09-10 | View → |
| 4 | FORM 4 | 2026-09-10 | View → |
| 4 | FORM 4 | 2026-09-10 | View → |
| 4 | FORM 4 | 2026-08-13 | View → |
| 10-Q | 10-Q | 2026-08-04 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-08-03 | View → |
| 4 | FORM 4 | 2026-06-10 | View → |
| 4 | FORM 4 | 2026-06-10 | View → |
| 4 | FORM 4 | 2026-06-10 | View → |
| 4 | FORM 4 | 2026-06-10 | View → |
| 8-K | 8-K | 2026-06-03 | View → |
| 4 | FORM 4 | 2026-05-26 | View → |
| 4 | FORM 4 | 2026-05-13 | View → |
| 4 | PRIMARY DOCUMENT | 2026-05-08 | View → |
| 10-Q | 10-Q | 2026-05-06 | View → |
| 8-K | 8-K | 2026-05-06 | View → |
| 4 | FORM 4 | 2026-04-27 | View → |
| 4 | FORM 4 | 2026-04-27 | View → |
| 4 | FORM 4 | 2026-04-27 | View → |
| 4 | FORM 4 | 2026-04-27 | View → |
| DEF 14A | DEF 14A | 2026-04-14 | View → |
| 4 | FORM 4 | 2026-03-18 | View → |
| 4 | FORM 4 | 2026-03-10 | View → |
| 4 | FORM 4 | 2026-03-10 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $5.26
- Market Cap
- $469.82 million
- 52-Week Range
- $3.95 – $6.50
- Average Volume
- 1.06 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.